HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Megumi Sano Selected Research

Drug Therapy (Chemotherapy)

10/2018[A Case of Neuroendocrine Carcinoma of the Ascending Colon That Responded Completely to Chemotherapy].
10/2018[A Case of Stage IV Rectal Cancer Achieving Long-Term Stable Disease Treated with Chemotherapy and Residual Tumor Resection].
10/2018[Analyses of Relapsed Cases after Oxaliplatin-Based Adjuvant Chemotherapy for Colorectal Cancer with Cur A Resection].
10/2017[Standard Chemotherapy with Bevacizumab as First-Line Therapy for Metastatic Colorectal Cancer with RAS Mutation].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Megumi Sano Research Topics

Disease

3Neoplasm Metastasis (Metastasis)
10/2019 - 10/2018
2Rectal Neoplasms (Rectal Cancer)
10/2019 - 10/2018
2Colorectal Neoplasms (Colorectal Cancer)
10/2018 - 10/2017
1Endometrial Stromal Sarcoma
02/2024
1Endometriosis
01/2024
1Pelvic Infection
01/2024
1Infertility (Sterility)
01/2024
1Lymphatic Metastasis
10/2019
1Disease Progression
10/2019
1Neuroendocrine Carcinoma
10/2018
1Residual Neoplasm
10/2018
1Neoplasms (Cancer)
10/2018

Drug/Important Bio-Agent (IBA)

4Bevacizumab (Avastin)FDA Link
10/2019 - 10/2017
1Cyclin-Dependent Kinase Inhibitor p16IBA
02/2024
1regorafenibIBA
10/2019
1RamucirumabIBA
10/2019
1trifluridine tipiracil drug combinationIBA
10/2019
1Fluorouracil (Carac)FDA LinkGeneric
10/2018
1Oxaliplatin (Eloxatin)FDA LinkGeneric
10/2018

Therapy/Procedure

4Drug Therapy (Chemotherapy)
10/2018 - 10/2017
3Therapeutics
10/2019 - 10/2017
1Treatment Delay
01/2024
1Heavy Ion Radiotherapy
10/2019
1Surgical Amputation (Amputations)
10/2018
1Adjuvant Chemotherapy
10/2018